U.K. Biotech Learns Lessons From History, Says BIA Head
This article was originally published in The Pink Sheet Daily
Executive Summary
Adversity has honed a solid foundation for U.K. biotech that might be better placed to resist cyclical changes in investor sentiment than the U.S., proposes the head of the U.K biotech industry association.